148 filings
Page 5 of 8
424B3
rbz9do2dq90b a6348a
28 Jun 21
Prospectus supplement
9:18am
424B3
x394a 8e17a76ga6j8
28 Jun 21
Prospectus supplement
9:17am
6-K
01m6ln43w50yo unjqt7
28 Jun 21
Current report (foreign)
9:16am
UPLOAD
t5ajqbu
23 Jun 21
Letter from SEC
12:00am
425
45d38
15 Jun 21
Business combination disclosure
4:28pm
F-4
9hh8yzyke7jyvw83p
15 Jun 21
Registration of securities (foreign)
12:00am
424B3
tmljb
7 Jun 21
Prospectus supplement
9:16am
424B3
gp5s xggppzpd36xvux
7 Jun 21
Prospectus supplement
9:16am
6-K
c2kqpzf219fgf
7 Jun 21
FDA confirms NDA for Oleogel-S10 will not require an Advisory Committee Meeting
9:13am
424B3
f2a9d3n
3 Jun 21
Prospectus supplement
6:06am
424B3
wd4g0i
3 Jun 21
Prospectus supplement
6:06am
6-K
xnq0lq1e3dx3ud
3 Jun 21
FDA Grants Priority Review for New Drug Application for Oleogel-S10 for the Treatment of Epidermolysis Bullosa
6:03am
424B3
pvu748kh ekuzhj
2 Jun 21
Prospectus supplement
10:10am
424B3
02h6ut8q8
2 Jun 21
Prospectus supplement
10:09am
424B3
tu7mi6b2 ga
2 Jun 21
Prospectus supplement
10:08am
6-K
ckqj4pkd1pwmwnl
2 Jun 21
Amryt Announces FDA Acceptance of New Drug Application for Oleogel-S10 for the Treatment of Epidermolysis Bullosa
9:02am
425
6ch65w4iqj85bxmg80xu
5 May 21
Business combination disclosure
5:27pm
425
jok0l
5 May 21
Business combination disclosure
5:26pm
425
3nr7gm2u
5 May 21
Business combination disclosure
5:25pm
425
34gjyt9i9u etcg52
5 May 21
Business combination disclosure
5:24pm